SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-13-000424
Filing Date
2013-02-15
Accepted
2013-02-15 16:58:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 sc13da109073bio_01112013.htm SC 13D/A 48208
  Complete submission text file 0000921895-13-000424.txt   50036
Mailing Address 12270 WILKINS AVENUE ROCKVILLE MD 20852
Business Address 12270 WILKINS AVENUE ROCKVILLE MD 20852 301-770-3099
Biota Pharmaceuticals, Inc. (Subject) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D/A | Act: 34 | File No.: 005-31596 | Film No.: 13620356
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 630 FIFTH AVENUE SUITE 2260 NEW YORK NY 10020
Business Address 630 FIFTH AVENUE SUITE 2600 NEW YORK NY 10020 201-934-2000
Xstelos Holdings, Inc. (Filed by) CIK: 0001540145 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations